Ozempic Reduces Risk of Death from Diabetes and Kidney Disease
The diabetes medication Ozempic, also marketed as the weight loss drug Wegovy has demonstrated another health benefit. According to new clinical trial data presented at a conference in Stockholm, semaglutide, the active ingredient in both drugs reduces the risk of kidney failure and death in individuals with type 2 diabetes and chronic kidney disease.